Nyrada Inc – Nyrada Commences Walter Reed Traumatic Brain Injury Study

Highlights:

•Walter Reed Army Institute of Research study of NYR-BI03 in traumatic brain injury has commenced and is expected to conclude in 2HCY2024.
•Separately, the first in-human Phase I clinical trial of NYR-BI03 remains on track to commence in 4QCY2024.